Proanthocyanidin and fish oil potent activity against cisplatin-induced renal cell cycle arrest and apoptosis in rats

Renal Failure
Hanaa A HassanElsamra A El-Sayed

Abstract

Cisplatin is an effective chemotherapeutic agent that displays dose-limiting nephrotoxicity. In the present study, the efficacy of grape seed proanthocyanidin extract (GSPE: 100 mg/kg/day) and fish oil (FO: 5 mL/kg/day) against cisplatin-induced nephrotoxicity was evaluated in terms of DNA damage, histopathological changes and expression levels of molecular markers of apoptosis. The administration of cisplatin (CP) (7 mg/kg) results in an increasing percentage of S-phase, G2/M and apoptosis. Furthermore, CP induces apoptosis as indicated by an elevation of renal caspase-3 and reduction in the expression of BCL-2. In addition to occurred renal histopathological changes as manifested by tubular degeneration, degenerative glomerulus, necrotic tubular cells, and cell debris. On the other hand, the administration of GSPE or FO pre-cisplatin treatment can be ameliorated the current DNA cell cycle alterations by the restoration of expression of proteins related to apoptosis and reduced the undesirable renal histopathological changes. So, it can be concluded that the consumption of GSPE or FO might be useful for minimizing nephrotoxicity caused by cisplatin chemotherapy through their anti-apoptotic and antioxidant properties.

References

Apr 1, 1977·Cancer·J C Gonzales-VitaleS S Sternberg
Sep 1, 1991·The American Journal of Clinical Nutrition·A P Simopoulos
Feb 1, 1974·The Journal of Cell Biology·P N Dean, J H Jett
Sep 15, 1994·Biochemical and Biophysical Research Communications·H MasudaU Takahama
Jan 1, 1996·Genes & Development·E White
Apr 1, 1996·The American Journal of Physiology·W LieberthalJ Levine
Jan 29, 2000·FEBS Letters·Y Tsujimoto, S Shimizu
Apr 1, 2000·Biochimica Et Biophysica Acta·R R ThakkarW D Ehringer
Oct 11, 2001·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·B S De Martinis, M D Bianchi
Apr 17, 2002·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·J YamakoshiM Kikuchi
Jun 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Brian S Cummings, Rick G Schnellmann
Aug 15, 2002·Archives of Biochemistry and Biophysics·BaoJun ChangMasayasu Inoue
Nov 22, 2002·Journal of the American Society of Nephrology : JASN·Margaret ParkJess Thoene
Mar 22, 2003·The Journal of Pharmacology and Experimental Therapeutics·Minoru SatohHirofumi Makino
Jul 17, 2003·American Journal of Physiology. Renal Physiology·Ganesan Ramesh, W Brian Reeves
Sep 19, 2003·Seminars in Nephrology·Istvan Arany, Robert L Safirstein
Jul 1, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·H Ramazan YilmazSerdar Gergerlioglu
Dec 30, 2004·Journal of Molecular and Cellular Cardiology·Christopher P Baines, Jeffery D Molkentin
Jan 14, 2005·Journal of the American Society of Nephrology : JASN·Alexei G BasnakianSudhir V Shah
Mar 25, 2005·Nature Reviews. Drug Discovery·Dong Wang, Stephen J Lippard
Mar 15, 2006·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Badreldin H Ali, Mansour S Al Moundhri
Mar 16, 2006·The American Journal of Surgical Pathology·Mark R CarterChristopher D M Fletcher
Jun 15, 2007·Journal of Gastroenterology and Hepatology·Ender DulunduGoksel Sener
Aug 19, 2007·The American Journal of the Medical Sciences·Xin YaoKenneth Nugent
Feb 15, 2008·Kidney International·N Pabla, Z Dong
Jun 13, 2008·Pulmonary Pharmacology & Therapeutics·Ali A HemmatiMehdi Samei
Nov 7, 2008·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Yolanda I Chirino, José Pedraza-Chaverri
Mar 2, 2010·Archives of Pharmacal Research·Mi-Ok ShinJeon-Ok Moon
May 4, 2010·The Journal of Pharmacology and Experimental Therapeutics·Sonia CamanoAlberto Tejedor
Aug 14, 2010·Cell Death and Differentiation·R NúñezF J López-Hernández
May 1, 2008·Environmental Toxicology and Pharmacology·Amr A FouadWafaey Gomaa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.